Date: 2014-10-28
Type of information: Nomination
Compound: vice president
Company: Catalyst Pharmaceutical Partners (USA - FL)
Therapeutic area: Rare diseases
Type agreement: nomination
Action mechanism:
Disease:
Details:
- • On October 28, 2014, Catalyst Pharmaceutical Partners announced the appointment of David J. Caponera to the newly created position, vice president, patient advocacy and reimbursement, effective immediately. Mr. Caponera will report to David D. Muth, executive vice president, corporate development. As vice president, patient advocacy and reimbursement, Mr. Caponera will be responsible for developing the strategy and managing Catalyst\'s patient advocacy programs, reimbursement and patient assistant initiatives.
- Mr. Caponera has over 30 years of successful healthcare experience ranging from clinical development, managing payer operations, extensive orphan drug product launches and implementing reimbursement and patient advocacy programs, with the last 15 years focused on rare diseases and orphan products. He most recently served as the Vice President, Patient Advocacy and Reimbursement for Aegerion Pharmaceuticals, Inc., where he established and built its patient advocacy and patient assistance organizations for the launch of Juxtapid™ the company\'s first ultra-rare disease product. Prior to that he was the Director, Access Services for Pfizer, Inc., where he developed a global patient access network for the launch of Elelyso™ for ultra-rare Gaucher disease. He also served as Senior Director of Reimbursement and Distribution for Amicus Therapeutics, Inc., Vice President, Strategic Initiatives for Theracom, Inc., and Senior Director, Patient and Product Services for Genzyme Corporation. At Genzyme he led the case management functions for multiple orphan products, developed the reimbursement and patient management programs for two new product launches and directed the customer services functions. In addition, Mr. Caponera has held positions at Blue Cross Blue Shield of Massachusetts as Product Manager for Managed Care and Harvard Community Health Plan (now Harvard Pilgrim Health Care).
Financial terms:
Latest news:
Is general: Yes
